Navigation Links
Schering-Plough Reports Financial Results for 2009 Second Quarter
Date:7/21/2009

78 (14%) 128 152 (16%) INTRON 67 61 10% 121 116 4% PROVENTIL / ALBUTEROL 56 38 46% 110 89 24% ASMANEX 54 48 12% 103 91 14% SUBUTEX / SUBOXONE 52 62 (15%) 102 115 (12%) REMERON 50 61 (18%) 100 129 (22%) ELOCON 45 47 (4%) 87 92 (6%) CERAZETTE 46 49 (6%) 85 93 (8%) NOXAFIL 43 38 14% 82 72 15% IMPLANON 43 44 (1%) 80 82 (2%) MERCILON 33 47 (30%) 68 90 (25%) LIVIAL 39 50 (22%) 72 95 (24%) MARVELON 36 40 (9%) 68 77 (13%) ZEMURON 33 67 (51%) 65 130 (50%) FORADIL 25 25 (1%) 48 51 (4%) Other Pharmaceuticals 735 755 (3%) 1,396 1,458 (4%) ANIMAL HEALTH 677 818 (17%) 1,307 1,540 (15%) CONSUMER HEALTH CARE 381 401 (5%) 765 778 (2%) OTC 184 181 2% 416 389 7% OTC CLARITIN 108 120 (10%) 257 258 - MiraLAX 36 28 30% 73 54 36% Other OTC 40 33 22% 86 77 11% Foot Care 101 105 (4%) 174 190 (8%) Sun Care 96 115 (17%) 175 199 (12%) -- --- --- --- CONSOLIDATED GAAP NET SALES $4,647 $4,921 (6%) $9,040 $9,57
'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 /PRNewswire/ - JSS Medical Research Inc., a Montreal ... concluded the acquisition of Max Neeman International (MNI), with head office ... are located in Ahmedabad, Bangalore , ... US subsidiary, a regional office is located North Carolina, ... by the recent equity investment transaction into JSS with Capital Croissance ...
(Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - Fluorinov ... to announce the appointment of Dr. Roger J ... experience guiding biotech companies in matters including corporate ... leadership team and adds significant regulatory expertise as ... Dr. Garceau brings 30 years of pharmaceutical development ...
(Date:5/4/2015)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... medical needs in the areas of inflammation, oncology and ... data from three of its biodefense programs at the ... on May 12-14, 2015 to be held at the ... St. Louis MO 63101. ...
(Date:5/4/2015)... 4, 2015   Sentrian ™, the Remote Patient ... with the Scripps Translational Science Institute (STSI) ... patients with chronic obstructive pulmonary disease (COPD), a chronic ... the nation,s third leading cause of death. The patients ... System , a wholly owned subsidiary of Anthem.   ...
Breaking Biology Technology:JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 2Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5
... - Employers who are looking for health information technology ... have to wait a while longer, according to the ... ,Stephen Lieber, president and CEO of the Healthcare ... electronic health records and improving interoperability between facilities remain ...
... - Wisconsin attracts far fewer defense research dollars annually ... of public and private initiatives are quietly positioning the ... , ,These projects and others like them could thrive ... responds to the unique threats it poses. Tom Still, ...
... - Last Sunday morning, in the free-wheeling environment ... shared secrets and strategies from her forthcoming book, titled ... she expects to publish next year. , ,In her ... Huber provided advice about maximizing efficiency and minimizing hurt ...
Cached Biology Technology:CEO of healthcare group still hopeful IT will save employers money 2CEO of healthcare group still hopeful IT will save employers money 3Chippewa Valley firms land more defense work 2Chippewa Valley firms land more defense work 3Chippewa Valley firms land more defense work 4Chippewa Valley firms land more defense work 5Chippewa Valley firms land more defense work 6Chippewa Valley firms land more defense work 7BarCamp talk turns to Internet dating 2BarCamp talk turns to Internet dating 3
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... Fingerprint Cards (FPC) has received ... the distributor World Peace Industrial Group (WPI), part of ... the major part of the shipments will take place ... smartphone manufacturers in China . The ... communicated revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... removes excess signaling molecules to prevent them from damaging cilia, ... published in the December 28 issue of the Journal ... cause a range of diseases including Bardet-Biedl syndrome (BBS), a ... Seven of these form a complex called the BBSome, but ...
... 2009. Emerald BioStructures (formerly deCODE biostructures) announced ... advance online issue of Nature Biotechnology , ... to engineer new allosteric small molecule modulators of ... According to the paper, the researchers established the ...
... the first time that insects, like mammals, use vision rather ... to high-speed video cameras technology the BBC uses to ... film desert locusts stepping along the rungs of a miniature ... to perform complex tasks, such as visually-guided limb control, usually ...
Cached Biology News:Emerald BioStructures announces discovery of small molecule modulators of PDE4 2Ladder-walking locusts show big brains aren't always best 2
Tissue culture grade....
Tris-Hepes kit of BG-163 & BG-165 (order number BG-166)...
... Translation System is ideal for both radioactive ... Translation System: Provides five pre-mixed nucleotide ... Yields >10 8 cpm/g control ... to monitor the performance of the system ...
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Biology Products: